1.
Tetrahedron Lett
; 88: 153590, 2022 Jan 05.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34908617
RESUMEN
Remdesivir, the first drug approved by the FDA to treat COVID-19, is in high demand for patients infected with the SARS-CoV-2 virus. Herein, we report a facile approach minimizing the protecting group manipulations to afford remdesivir in good overall yield.